Health care utilization (HCU) by breast cancer (BC) and non-Hodgkin lymphoma (NHL) patients (pts) with chemotherapy (CT) induced febrile neutropenia (FN) in the Netherlands

被引：0
|
作者：
Gelderblom, Hans
Lugtenburg, Pieternella
Nortier, J. W. R.
van Herk-Sukel, Myrthe
Issa, Djamila
Jager, A.
De La Orden, Margarita
van der Werf-Langenberg, Mirte
Houweling, Leanne
De Jong, Floris Aart
机构：
[1] Leiden Univ, Dept Clin Oncol, Med Ctr, Leiden, Netherlands
[2] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands
[3] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands
[5] Erasmus Univ, Dept Med Oncol, Med Ctr, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands
[6] Amgen Int, Ctr Observat Res, Uxbridge, Middx, England
[7] Amgen BV, Med Dept Oncol & Hematol, Breda, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16526
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Chemotherapy-induced febrile neutropenia (FN) and FN prevention strategies in cancer care in the US Veterans Health Administration (VHA)
    Barron, Richard L.
    Wang, Li
    Baser, Onur
    Langeberg, Wendy J.
    Dale, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice
    Weycker, Derek
    Danel, Aurelie
    Marciniak, Anne
    Bendall, Kate
    Lipsitz, Michael
    Pettengell, Ruth
    BMC CANCER, 2012, 12
  • [23] Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice
    Derek Weycker
    Aurelie Danel
    Anne Marciniak
    Kate Bendall
    Michael Lipsitz
    Ruth Pettengell
    BMC Cancer, 12
  • [24] Prophylactic pegfilgrastim is safe and effective for chemotherapy-induced neutropenia in patients with Hodgkin disease and non-Hodgkin lymphoma
    Gregory, S
    Grigg, A
    Moore, T
    PROCEEDINGS OF THE XVII MEETING INTERNATIONAL SOCIETY OF HAEMATOLOGY (EUROPEAN AND AFRICAN DIVISION), 2003, : 231 - 237
  • [25] Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN study
    Ishikawa, Takashi
    Sakamaki, Kentaro
    Narui, Kazutaka
    Kaise, Hiroshi
    Tsugawa, Koichiro
    Ichikawa, Yasushi
    Mukai, Hirofumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (07) : 692 - 695
  • [26] Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN Study
    Ishikawa, Takashi
    Sakamaki, Kentaro
    Narui, Kazutaka
    Nishimura, Hideki
    Sangai, Takafumi
    Tamaki, Kentaro
    Hasegawa, Yoshie
    Watanabe, Ken-ichi
    Suganuma, Nobuyasu
    Michishita, Shintaro
    Sugae, Sadatoshi
    Aiharya, Tomohiko
    Tsugawa, Koichiro
    Kaise, Hiroshi
    Mukai, Hirofumi
    CANCER RESEARCH, 2020, 80 (04)
  • [27] Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy
    Lyman, GH
    Morrison, VA
    Dale, DC
    Crawford, J
    Delgado, DJ
    Fridman, M
    LEUKEMIA & LYMPHOMA, 2003, 44 (12) : 2069 - 2076
  • [28] PREDICTORS OF G-CSF PROPHYLAXIS IN THE FIRST CYCLE OF CHEMOTHERAPY FOR FEBRILE NEUTROPENIA IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA
    Lugtenburg, P.
    Asubonteng, J.
    DeCosta, L.
    Szabo, Z.
    Page, J. H.
    Wetten, S.
    HAEMATOLOGICA, 2014, 99 : 196 - 196
  • [29] Metabolic effects of chemotherapy on the brain in Non-Hodgkin Lymphoma (NHL) patients as measured on FDG-PET/CT
    Saboury, B.
    JinHyung, A. A.
    Hofheinz, F.
    Alavi, A.
    Torigian, D. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S427 - S427
  • [30] ECONOMIC MODEL OF GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) IN PRIMARY (PP) AND SECONDARY PROPHYLAXIS (SP) OF FEBRILE NEUTROPENIA (FN) IN NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS UNDERGOING CHEMOTHERAPY IN FRANCE
    Perrier, L.
    Sebban, C.
    Leon, N.
    Maurel, F.
    Cohen-Nizard, S.
    De Liege, F.
    VALUE IN HEALTH, 2011, 14 (07) : A450 - A450
12345